Trial site
Texas Diabetes & Endocrinology, P.A.
- 7running trials
- 12closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes6 trials
- Type 1 diabetes4 trials
- Alzheimer disease2 trials
- Chronic kidney disease1 trial
- Phase
- Phase 310 trials
- Phase 27 trials
- Phase 41 trial
- Status
- Completed12 trials
- Active, not recruiting6 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company11 trials
- Hoffmann-La Roche3 trials
- Carmot Therapeutics, Inc.1 trial
- Deka Research and Development1 trial
- Mannkind Corporation1 trial
- and 2 more
Running trials
Recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 1 diabetes1 recruiting
Closed trials
Recruiting
Completed
Completed
Innovative Automated Insulin Delivery System for Type 2 Diabetes
Completed
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
Completed
Completed
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 12 Nov 2026